Surfactant protein-A levels increase during Pneumocystis carinii pneumonia in the rat

European Respiratory Journal

Volumn 9, Issue 3, 1996, Pages 565-570

  Phelps, D S ^a   Umstead, T M ^a   Rose, R M ^b   Fishman, J A ^c  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b CYTEL CORPORATION   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

corticosteroid; lung; opportunistic infection; phagocytosis; surfactant protein A

Indexed keywords

DEXAMETHASONE; MESSENGER RNA; PROTEIN A; SURFACTANT ASSOCIATED PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DNA PROBE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LUNG LAVAGE; NONHUMAN; OPPORTUNISTIC INFECTION; PHAGOCYTOSIS; PNEUMOCYSTIS CARINII; PRIORITY JOURNAL; RAT;

ANIMALS; BLOTTING, NORTHERN; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOSUPPRESSION; PHAGOCYTOSIS; PNEUMONIA, PNEUMOCYSTIS; PROTEOLIPIDS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; PULMONARY SURFACTANTS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 0029887803     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.96.09030565     Document Type: Article

References (29)

1. Fishman JA. Pneumocystis carinii pneumonia. In: Fishman AP, ed. Update: Pulmonary Diseases and Disorders. New York, McGraw-Hill, 1992; pp. 263-286.
2. Walzer PD. Pneumocystis carinii: recent advances in basic biology and their clinical application. AIDS 1993; 7: 1293-1305.
3. Phelps DS, Rose RM. Increased recovery of surfactant protein-A in AIDS-related pneumonia. Am Rev Respir Dis 1991; 143: 1072-1075.
4. Escamilla R, Prevost MC, Hermant C, Caratero A, Cariven C, Krempf M. Surfactant analysis during Pneumocystis carinii pneumonia in HIV-infected patients. Chest 1992; 101: 1558-1562.
5. Hoffman AGD, Lawrence MG, Ognibene FP, et al. Reduction of pulmonary surfactant in patients with human immunodeficiency virus infection and Pneumocystis carinii pneumonia. Chest 1992; 102: 1730-1736.
6. Rose RM, Catalano PJ, Koziel H, Furlong ST. Abnormal lipid composition of bronchoalveolar lavage fluid obtained from individuals with AIDS-related lung disease. Am J Respir Crit Care Med 1994; 149: 332-338.
7. 2 in experimental Pneumocystis carinii pneumonia. Am Rev Respir Dis 1986; 134: 526-531.
8. Voss T, Melchers K, Scheirle G, Schafer KP. Structural comparison of recombinant pulmonary surfactant protein SP-A derived from two human coding sequences: implications for the chain composition of natural human SP-A. Am J Respir Cell Mol Biol 1991; 4: 88-94.
9. Thiel S, Reid KBM. Structures and functions associated with the group of mammalian lectins containing collagen-like sequences. FEBS Lett 1989; 250: 78-84.
10. Koziel H, O'Riordan D, Phelps D, et al. Surfactant protein-A inhibits binding and internalization of Pneumocystis carinii by alveolar macrophages. Am Rev Respir Dis 1992; 145: A247 (Abstract).
11. Manz-Keinke H, Plattner H, Schlepper-Shafer J. Lung surfactant protein-A (SP-A) enhances serum-independent phagocytosis of bacteria by alveolar macrophages. Eur J Cell Biol 1992; 57: 95-100.
12. McNeely TB, Coonrod JD. Comparison of the opsonic activity of human surfactant protein-A for Staphylococcus aureus and Streptococcus pneumoniae with rabbit and human macrophages. J Infect Dis 1993; 167: 91-97.
13. McNeely TB, Coonrod JD. Aggregation and opsonization of Type A but not Type B Hemophilus influenzas by surfactant protein-A. Am J Respir Cell Mol Biol 1994; 11: 114-122.
14. Van Iwaarden F, Welmers B, Verhoef J, Haagsman HP, Van Golde LMG. Pulmonary surfactant protein-A enhances the host-defense mechanism of rat alveolar macrophages. Am J Respir Cell Mol Biol 1990; 2: 91-98.
15. Van Iwaarden JF, Van Strijp JAG, Ebskamp MJM, Welmers AC, Verhoef J, Van Golde LMG. Surfactant protein-A is opsonin in phagocytosis of Herpes simplex virus type-1 by rat alveolar macrophages. Am J Physiol (Lung Cell Mol Physiol 5) 1991; 261: L204-L209.
16. Wright JR, Youmans DC. Pulmonary surfactant protein-A stimulates chemotaxis of alveolar macrophage. Am J Physiol (Lung Cell Mol Physiol 8) 1993; 264: L338-L344.
17. Kremlev SG, Umstead TM, Phelps DS. Effects of surfactant protein-A and surfactant lipids on lymphocyte proliferation in vitro. Am J Physiol (Lung Cell Mol Physiol 11) 1994; 267: L357-L364.
18. Kremlev SG, Phelps DS. Surfactant protein-A stimulation of inflammatory cytokine and immunoglobulin production. Am J Physiol (Lung Cell Mol Physiol 11) 1994; 267: L712-L719.
19. Floros J, Phelps DS, Harding HP, Church S, Ware J. Postnatal stimulation of rat surfactant protein-A synthesis by dexamethasone. Am J Physiol (Lung Cell Mol Physiol 1) 1989; 257: L137-L143.
20. Zimmerman PE, Voelker DR, McCormack FX, Paulsrud JR, Martin WJ. 120 kDa surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein-A. J Clin Invest 1992; 89: 143-149.
21. Bartlett MS, Fishman JA, Queener SF, Durkin MM, Jay MA, Smith JW. New rat model of Pneumocystis carinii infection. J Clin Microbiol 1988; 26: 1100-1102.
22. Rooney SA, Gobran LI, Umstead TM, Phelps DS. Secretion of surfactant protein-A from rat type II pneumocytes. Am J Physiol (Lung Cell Mol Physiol 9) 1993; 265: L586-L590.
23. Fishman JA. A gene family related to the major antigen gene of Pneumocystis. Bristol-Myers Squibb Symposium on Cell and Molecular Biology of Bacterial-Host Cell Interactions. Monterey, CA, February 1993.
24. Kondil O, Fishman JA, Koziel H, Pinkston P, Rose RM, Remold HG. Human immunodeficiency virus type I infection of human macrophages modulates the cytokine response to Pneumocystis carinii. Infect Immun 1994; 62: 644-650.
25. Ballard PL, Liley HG, Gonzales LW, et al. Interferon-gamma and synthesis of surfactant components by cultured human fetal lung. Am J Respir Cell Mol Biol 1990; 2: 137-143.
26. Dranoff G, Crawford AD, Sadelain M, et al. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 1994; 264: 713-716.
27. Whitsett JA, Clark JC, Wispe JR, Pryhuber GS. Effects of TNF-alpha and phorbol ester on human surfactant protein and MnSOD gene transcription in vitro. Am J Physiol (Lung Cell Mol Physiol 6) 1992; 262: L688-L693.
28. Thomassen MJ, Meeker DP, Antal JM, Connors MJ, Wiedemann HP. Synthetic surfactant (Exosurf) inhibits endotoxin-stimulated cytokine secretion by human alveolar macrophages. Am J Respir Cell Mol Biol 1992; 7: 257-260.
29. Thomassen MJ, Antal JM, Connors MJ, Meeker DP, Wiedemann HP. Characterization of Exosurf (surfactant)-mediated suppression of stimulated human alveolar macrophage cytokine responses. Am J Respir Cell Mol Biol 1994; 10: 399-404.